Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

FRESENIUS MEDICAL CARE DANMARK A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   0.6% 0.7% 0.5% 0.5% 0.8% 0.5% 5.3% 5.0%   Credit score (0-100)   98 96 99 98 90 98 42 44   Credit rating   AA AA AA AA A AAA BBB BBB   Credit limit (kDKK)   4,512.1 2,746.7 4,869.1 4,358.7 3,068.3 3,311.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   35,865 25,839 36,278 31,879 34,535 26,885 0.0 0.0   EBITDA   16,870 3,502 18,416 14,122 10,105 6,038 0.0 0.0   EBIT   13,264 393 15,628 11,509 7,135 3,862 0.0 0.0   Pre-tax profit (PTP)   13,191.0 366.0 15,548.0 11,437.0 7,264.0 4,785.0 0.0 0.0   Net earnings   10,271.0 256.0 12,120.0 9,616.0 5,519.0 2,957.0 0.0 0.0   Pre-tax profit without non-rec. items   13,191 365 15,548 11,437 7,264 4,785 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   6,307 5,366 4,312 5,072 4,111 5,159 0.0 0.0   Shareholders equity total   33,709 23,694 35,558 33,054 28,957 26,395 25,895 25,895   Interest-bearing liabilities   201 0.0 704 276 0.0 15,947 0.0 0.0   Balance sheet total (assets)   41,694 34,446 49,523 46,843 38,642 54,632 25,895 25,895   Net Debt   201 -3.0 704 276 0.0 15,947 -25,769 -25,769     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   35,865 25,839 36,278 31,879 34,535 26,885 0.0 0.0   Gross profit growth   20.0% -28.0% 40.4% -12.1% 8.3% -22.2% -100.0% 0.0%   Employees   24 24 24 25 25 22 0 0   Employee growth %   0.0% 0.0% 0.0% 4.2% 0.0% -12.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   41,694 34,446 49,523 46,843 38,642 54,632 25,895 25,895   Balance sheet change%   1.8% -17.4% 43.8% -5.4% -17.5% 41.4% -52.6% 0.0%   Added value   16,870.0 3,502.0 18,416.0 14,122.0 9,748.0 6,038.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -4,039 -4,829 -4,620 -2,126 -4,899 -1,315 -5,176 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   37.0% 1.5% 43.1% 36.1% 20.7% 14.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   32.1% 1.1% 37.2% 23.9% 17.2% 10.3% 0.0% 0.0%   ROI %   39.9% 1.4% 50.2% 32.4% 23.6% 13.5% 0.0% 0.0%   ROE %   32.2% 0.9% 40.9% 28.0% 17.8% 10.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   80.8% 68.8% 71.8% 73.0% 75.3% 48.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   1.2% -0.1% 3.8% 2.0% 0.0% 264.1% 0.0% 0.0%   Gearing %   0.6% 0.0% 2.0% 0.8% 0.0% 60.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.7% 39.8% 25.0% 20.2% 59.4% 0.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   3.2 1.8 2.6 2.8 3.2 1.3 0.0 0.0   Current Ratio   4.2 2.7 3.5 3.3 4.8 1.8 0.0 0.0   Cash and cash equivalent   0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   24,140.0 16,371.0 30,889.0 27,888.0 26,665.0 22,291.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   703 146 767 565 390 274 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   703 146 767 565 404 274 0 0   EBIT / employee   553 16 651 460 285 176 0 0   Net earnings / employee   428 11 505 385 221 134 0 0